COEP
NASDAQCoeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc. (COEP) is a Biotechnology: Biological Products (No Diagnostic Substances) company listed on NASDAQ. There were no new wire items for COEP in the last 30 days. The most recent was published Oct 5, 2026.
News · 26 weeks37-100%
2026-05-102026-11-01
Mix1590d
- Insider10(67%)
- SEC Filings5(33%)
Latest news
25 items- INSIDERSEC Form 4 filed by Coeptis Therapeutics Holdings Inc.4 - Z Squared Inc. (0001759186) (Issuer)
- INSIDERChief Executive Officer Halabu David Elias converted options into 19,737 shares (SEC Form 4)4 - Z Squared Inc. (0001759186) (Issuer)
- INSIDERDirector Sohn Adam Craig converted options into 1,370 shares (SEC Form 4)4 - Z Squared Inc. (0001759186) (Issuer)
- INSIDERDirector Fuerst Bryan Eric converted options into 1,370 shares (SEC Form 4)4 - Z Squared Inc. (0001759186) (Issuer)
- INSIDERDirector Cooper Kenneth Lyle converted options into 1,370 shares (SEC Form 4)4 - Z Squared Inc. (0001759186) (Issuer)
- INSIDERChief Technology Officer Harris Jeffery Keeslar converted options into 12,444 shares (SEC Form 4)4 - Z Squared Inc. (0001759186) (Issuer)
- INSIDERChief Financial Officer Cogley Brian converted options into 4,112 shares, increasing direct ownership by 18% to 26,612 units (SEC Form 4)4 - Z Squared Inc. (0001759186) (Issuer)
- INSIDERAmendment: Chief Marketing Officer Schadel Christopher Ryan bought $3,920 worth of shares (1,000 units at $3.92) and converted options into 3,169 shares (SEC Form 4)4/A - Z Squared Inc. (0001759186) (Issuer)
- SECCoeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Z Squared Inc. (0001759186) (Filer)
- SECCoeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Z Squared Inc. (0001759186) (Filer)
- SECCoeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Z Squared Inc. (0001759186) (Filer)
- INSIDERSEC Form 4 filed by Chief Technology Officer Harris Jeffery Keeslar4 - Z Squared Inc. (0001759186) (Issuer)
- SECSEC Form S-8 filed by Coeptis Therapeutics Holdings Inc.S-8 - Z Squared Inc. (0001759186) (Filer)
- INSIDERChief Marketing Officer Schadel Christopher Ryan bought $3,920 worth of shares (1,000 units at $3.92) (SEC Form 4)4 - Z Squared Inc. (0001759186) (Issuer)
- SECSEC Form 10-Q filed by Coeptis Therapeutics Holdings Inc.10-Q - Z Squared Inc. (0001759186) (Filer)
- SECCoeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Z Squared Inc. (0001759186) (Filer)
- SECSEC Form POSASR filed by Coeptis Therapeutics Holdings Inc.POSASR - Z Squared Inc. (0001759186) (Filer)
- SECCoeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Z Squared Inc. (0001759186) (Filer)
- SECCoeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Z Squared Inc. (0001759186) (Filer)
- SECCoeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Z Squared Inc. (0001759186) (Filer)
- INSIDERSEC Form 3 filed by new insider Harris Jeffery Keeslar3 - Z Squared Inc. (0001759186) (Issuer)
- SECCoeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Z Squared Inc. (0001759186) (Filer)
- SECCoeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - Z Squared Inc. (0001759186) (Filer)
- SECSEC Form S-1 filed by Coeptis Therapeutics Holdings Inc.S-1 - Z Squared Inc. (0001759186) (Filer)
- SECCoeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Z Squared Inc. (0001759186) (Filer)
COEP FAQ
6 questionsWhat is the latest news on COEP?
Quantisnow has not tracked any new filings, ratings or press releases for COEP in the last 30 days. The most recent wire item was published on October 5, 2026.Where does COEP stock trade?
Coeptis Therapeutics Holdings Inc. (COEP) is listed on NASDAQ.What sector and industry is COEP in?
Coeptis Therapeutics Holdings Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did Coeptis Therapeutics Holdings Inc. go public?
Coeptis Therapeutics Holdings Inc. (COEP) completed its IPO in 2020.What companies are similar to COEP?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), MRNA (Moderna Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.). Compare COEP side-by-side with any of them on Quantisnow.How can I track COEP on Quantisnow?
Quantisnow aggregates Coeptis Therapeutics Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow COEP to receive live email and push alerts on every new disclosure.